Cargando…

Clinical implications of germline mutations in breast cancer: TP53

PURPOSE: This review describes the prevalence of germline TP53 mutations, the risk of breast cancer and other cancers in mutation carriers and management implications for women with breast cancer and unaffected women. METHODS: Literature review of English language papers available through PubMed. RE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schon, Katherine, Tischkowitz, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790840/ https://www.ncbi.nlm.nih.gov/pubmed/29039119 http://dx.doi.org/10.1007/s10549-017-4531-y

Ejemplares similares

Clinical implications of germline mutations in breast cancer genes: RECQL
por: Bowden, A. Ramsay, et al.
Publicado: (2019)

Germline TP53 mutations in Finnish breast cancer patients
por: Rapakko, K, et al.
Publicado: (2000)

Germline TP53 mutational spectrum in French Canadians with breast cancer
por: Arcand, Suzanna L, et al.
Publicado: (2015)

Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020)

Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
por: Alyami, Hassan, et al.
Publicado: (2021)

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
por: Kwong, Ava, et al.
Publicado: (2020)

Germline mutation in the TP53 gene in uveal melanoma
por: Hajkova, Nikola, et al.
Publicado: (2018)

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
por: Grill, Sabine, et al.
Publicado: (2020)

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
por: Assumpção, Juliana G, et al.
Publicado: (2011)

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
por: Assumpção, Juliana G, et al.
Publicado: (2008)

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
por: Kai, Masaya, et al.
Publicado: (2022)

Number of rare germline CNVs and TP53 mutation types
por: Silva, Amanda G, et al.
Publicado: (2012)

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
por: Yi, Dandan, et al.
Publicado: (2019)

Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population
por: Gallardo-Alvarado, Lenny N., et al.
Publicado: (2019)

Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors
por: Aceto, Gitana Maria, et al.
Publicado: (2019)

Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients
por: Siraj, Abdul Khalid, et al.
Publicado: (2021)

Choroid Plexus Carcinomas With TP53 Germline Mutations: Management and Outcome
por: Li, Yanong, et al.
Publicado: (2021)

Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2016)

Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
por: Kim, Jinyong, et al.
Publicado: (2023)

Emerging insights into ethnic-specific TP53 germline variants
por: Fischer, Nicholas W, et al.
Publicado: (2023)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020)

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
por: Rapakko, K, et al.
Publicado: (2001)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark
por: Stoltze, Ulrik, et al.
Publicado: (2018)

Inherited and de novo germline TP53 mutations in adult-onset sarcoma
por: Thomas, David M, et al.
Publicado: (2012)

Inherited and de novo germline TP53 mutations in adult-onset sarcoma
por: Thomas, DM, et al.
Publicado: (2012)

Modeling the prevalent germline TP53 R337H mutation in mouse
por: Park, Ji-Hoon, et al.
Publicado: (2019)

Pathogenic germline TP53 mutations in adult sarcoma patients; implications for treatment and screening – description of an upcoming project
por: Mahendran, K, et al.
Publicado: (2012)

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
por: Alsner, J, et al.
Publicado: (2000)

The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy
por: Canale, Matteo, et al.
Publicado: (2022)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

Epidermal Growth Factor Receptor-mutated Lung Cancer as the Initial Manifestation of Germline TP53 Mutation Associated Cancer
por: Pathak, Surabhi, et al.
Publicado: (2018)

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
por: Prochazka, Katharina T., et al.
Publicado: (2019)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

RAD51C germline mutations in breast and ovarian cancer patients
por: Akbari, Mohammad R, et al.
Publicado: (2010)

The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
por: Brachova, Pavla, et al.
Publicado: (2013)

Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study)
por: Packwood, Kate, et al.
Publicado: (2019)

TP53 Mutations Promote Immunogenic Activity in Breast Cancer
por: Liu, Zhixian, et al.
Publicado: (2019)

Impact of TP53 mutations in Triple Negative Breast Cancer
por: Mitri, Zahi I., et al.
Publicado: (2022)

Blood functional assay for rapid clinical interpretation of germline TP53 variants
por: Raad, Sabine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tgvpkto75bi0o2ahk3tlc3avhq